Clopidogrel plus aspirin versus aspirin alone for preventing cardiovascular disease

  • Squizzato A
  • Keller T
  • Romualdi E
  • et al.
55Citations
Citations of this article
72Readers
Mendeley users who have this article in their library.
Get full text
This PDF is freely available from an open access repository. It may not have been peer-reviewed.

Abstract

Aspirin is the prophylactic antiplatelet drug of choice for people with cardiovascular disease. Adding a second antiplatelet drug to aspirin may produce additional benefit for those at high risk and those with established cardiovascular disease.

Cite

CITATION STYLE

APA

Squizzato, A., Keller, T., Romualdi, E., & Middeldorp, S. (2011). Clopidogrel plus aspirin versus aspirin alone for preventing cardiovascular disease. Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.cd005158.pub3

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free